Subscribe to Updates in Legal, Economic & Regulatory Affairs

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Stephen Bent

Stephen Bent, Partner & Co-Chair, Life Sciences, Foley & Lardner LLPPartner & Co-Chair, Life Sciences
Foley & Lardner LLP
Member of the Law Council

Stephen A. Bent is Partner and co-leader of the Life Sciences Industry Team at Foley & Lardner in Washington, DC. He is also a member of the Biotechnology & Pharmaceutical Practice Group and the Health Care and Nanotechnology Industry Teams. Mr. Bent specializes on the legal issues associated with biotechnology asset valuation and management, venture capital, licensing and technology transfer, corporate acquisitions, and disputes involving biotechnology and pharmaceutical patents. He has developed an international reputation in biotechnology intellectual property law, with a number of publications to his credit in both scientific and legal journals, including articles titled "The Scylla & Charybdis Face Integrated Genomics," "Patents and Genomic Medicine," and "The Heat Is On: What is Driving Pharmaceutical Developments in the U.S. Now?" Mr. Bent has participate in a number of events on stem cell research and advanced pharmaceutical and biotech IP licensing. The Practical Law Company's 2004/2005 Cross Border Life Sciences Handbook ranks Mr. Bent as one of the top five U.S. life sciences attorneys in the IP category. He has also been selected by his peers for inclusion in "The Best Lawyers in America 2007" in the area of biotechnology law. (This is me - Update Profile)


Employment History
1987 - present Partner & Co-Chair, Life Sciences
Foley & Lardner LLP

GLG NewsSM Analyses by Stephen Bent(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Stephen Bent has not published any public GLG News analyses.
View all GLG News in Legal, Economic & Regulatory Affairs

GLG InstituteSM Seminars with Stephen Bent(?)

 
Stephen Bent has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Legal, Economic & Regulatory Affairs

Request a project with Stephen Bent








GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics